SCHEMBL17524123

SCHEMBL17524123

COc1ccc(/C(=C(/CCNC(=S)N2CCCC2)c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.52
▸ HPGD P15428 2/20 0.52
▸ ALOX5 P09917 1/20 0.52
▸ MAPT P10636 3/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ SMN1; SMN2 Q16637 4/20 0.50
▸ HTT P42858 2/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ TP53 P04637 1/20 0.49
▸ GAA P10253 3/20 0.48
▸ LMNA P02545 1/20 0.47
▸ PSMB1 P20618 4/20 0.47
▸ PSMB5 P28074 3/20 0.47
▸ PTGS2 P35354 2/20 0.47
▸ PSMB2 P49721 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ KMT2A Q03164 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17524122 1.00 ALDH1A1 (0.52) ALDH1A1HPGDALOX5MAPTL3MBTL1
SCHEMBL19181028 0.86 SMN1; SMN2 (0.54) ALDH1A1HPGDALOX5MAPTL3MBTL1
SCHEMBL17506009 0.86 SMN1; SMN2 (0.54) ALDH1A1HPGDALOX5MAPTL3MBTL1
SCHEMBL19181332 0.86 SMN1; SMN2 (0.54) ALDH1A1HPGDALOX5MAPTL3MBTL1
SCHEMBL17506001 0.86 SMN1; SMN2 (0.54) ALDH1A1HPGDALOX5MAPTL3MBTL1
SCHEMBL17505998 0.84 ALDH1A1 (0.47) ALDH1A1HPGDALOX5MAPTL3MBTL1
SCHEMBL19182066 0.84 ALDH1A1 (0.47) ALDH1A1HPGDALOX5MAPTL3MBTL1
SCHEMBL19181382 0.84 ALDH1A1 (0.47) ALDH1A1HPGDALOX5MAPTL3MBTL1
SCHEMBL17506006 0.84 ALDH1A1 (0.47) ALDH1A1HPGDALOX5MAPTL3MBTL1
SCHEMBL19200767 0.82 RAB9A (0.50) ALDH1A1HPGDALOX5MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170217914-A1 Novel Triarylethylene Compounds and Methods Using Same THE PENN STATE RESEARCH FOUNDATION 2017-08-03 — — US disclosed
WO-2016022325-A1 NOVEL TRIARYLETHYLENE COMPOUNDS AND METHODS USING SAME THE PENN STATE RESEARCH FOUNDATION (US) 2016-02-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170217914-A1 Novel Triarylethylene Compounds and Methods Using Same CYP46A1, GSTA2, GSTA1 ALDH1A1 176/4885HPGD 533/4885ALOX5 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback